Press Releases
September 20, 2023
Two-time Emmy® Award-Winning Actor, Eric Stonestreet, Partners with Iveric Bio to Raise Awareness of Geographic Atrophy (GA)
September 18, 2023
Iveric Bio Announces Positive 24-Month Topline Results from Phase 3 Study of IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy
August 18, 2023
European Medicines Agency Accepts Iveric Bio’s Marketing Authorization Application for Avacincaptad Pegol for Geographic Atrophy
August 5, 2023
Iveric Bio Receives U.S. FDA Approval for IZERVAY™ (avacincaptad pegol intravitreal solution), a New Treatment for Geographic Atrophy
July 5, 2023
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 2, 2023
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 24, 2023
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 30, 2023
Astellas Enters Into Definitive Agreement to Acquire Iveric Bio
April 23, 2023
Iveric Bio Announces New Functional Vision Loss Reduction Data from Avacincaptad Pegol GATHER Trials Presented at ARVO Annual Meeting
April 4, 2023